Loading…
2 companies · GEL, thousands · columns ordered by revenue
| Line item | Vivo Medical Group | Bokhua Cardiovascular C… |
|---|---|---|
| Total Revenue | 73,245 | 22,835 |
| Total COGS | -56,377 | -18,911 |
| Gross Profit | 16,868 | 3,924 |
| Gross Margin | 23.0% | 17.2% |
| Total Operating Expenses | -13,555 | -3,076 |
| EBITDA | 3,313 | 871 |
| EBITDA Margin | 4.5% | 3.8% |
| Total D&A | -418 | -72 |
| EBIT / Operating Income | 2,895 | 799 |
| Total Interest Income | 66 | — |
| Total Interest Expense | -4,257 | -888 |
| Total Other Income | 247 | 141 |
| Profit Before Tax | -1,049 | 52 |
| Total Income Tax | -228 | -68 |
| Net Profit / (Loss) | -1,277 | -16 |
| Net Margin | -1.7% | -0.1% |
| Other Comprehensive Income | 4,072 | 1,541 |
| Total Comprehensive Income | 2,795 | 1,525 |
| Other Operating Income | — | 23 |
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Vivo Medical Group | Healthcare Services | 4.5% | 33rd pct | 268 |
| Bokhua Cardiovascular C… | Healthcare Services | 3.8% | 31st pct | 268 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.